Fidia Pharma GmbH

Wholly owned subsidiary in Germany.

Third in the Group, in addition to Italian headquarters and the US subsidiary, Fidia Pharma GmbH represents an additional step in the company's internationalization plan, a higher penetration of Fidia's products in the European market and a more direct, stronger contribution to the spreading and widening of Italian research and industrial excellence worldwide.

Fidia Pharma GmbH will initially focus on the viscosupplementation for synovial joints and wound care areas, through products containing hyaluronic acid.

Learn more about the Company, visit

Founded in 2014

Headquartered in Monheim am Rhein


Find out more about Fidia’s product portfolio:

Go to the website


Fidia Farmaceutici has a specific module dedicated to Pharmaco-Vigilance in order to promptly reporting of suspected adverse reactions. If you suspect that you have had an adverse reaction while taking one of our products or you have found defects

Key Business Areas

Fidia operates in numerous therapeutic areas, providing specific, innovative treatments for commonly occurring pathologies with major socio-economic impact, namely:

- joint care
- ophthalmology
- active wound care
- neuroscience
- aesthetic medicine